Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference
Rhea-AI Summary
Pulmonx (Nasdaq: LUNG), a global leader in minimally invasive treatments for severe lung disease, has announced its participation in the Lake Street 8th Annual Best Ideas Growth Conference. The event is scheduled to take place on Thursday, September 14, 2024, in New York.
Pulmonx representatives will be engaging in investor meetings during the conference, providing an opportunity for the company to showcase its innovations and growth strategies in the field of lung disease treatment. This participation underscores Pulmonx's commitment to engaging with investors and sharing insights about its market position and future prospects.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, LUNG declined NaN%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
REDWOOD CITY, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in investor meetings at the Lake Street 8th Annual Best Ideas Growth Conference in New York on Thursday, September 14, 2024.
About Pulmonx Corporation
Pulmonx Corporation (Nasdaq: LUNG) is a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD). Pulmonx’s Zephyr® Endobronchial Valve, Chartis® Pulmonary Assessment System and StratX® Lung Analysis Platform are designed to assess and treat patients with severe emphysema/COPD who despite medical management are still profoundly symptomatic. Pulmonx received FDA pre-market approval to commercialize the Zephyr Valve following its designation as a “breakthrough device.” The Zephyr Valve is commercially available in more than 25 countries, is included in global treatment guidelines and is widely considered a standard of care treatment option for improving breathing, activity and quality of life in patients with severe emphysema. For more information on the Zephyr Valves and the company, please visit www.Pulmonx.com.
Contact
Brian Johnston
Gilmartin Group
investors@pulmonx.com
FAQ
When is Pulmonx (LUNG) participating in the Lake Street Best Ideas Growth Conference?
What type of meetings will Pulmonx (LUNG) be involved in at the conference?
What is Pulmonx's (LUNG) main focus as a company?
Where is the Lake Street Best Ideas Growth Conference being held in 2024?
